184 related articles for article (PubMed ID: 9294701)
1. Synergistic antimycobacterial activity between ethambutol and the beta-lactam drug cefepime.
Abate G; Hoffner SE
Diagn Microbiol Infect Dis; 1997 Jul; 28(3):119-22. PubMed ID: 9294701
[TBL] [Abstract][Full Text] [Related]
2. Synergistic activity of rifampicin and ethambutol against slow-growing nontuberculous mycobacteria is currently of questionable clinical significance.
van Ingen J; Hoefsloot W; Mouton JW; Boeree MJ; van Soolingen D
Int J Antimicrob Agents; 2013 Jul; 42(1):80-2. PubMed ID: 23664674
[TBL] [Abstract][Full Text] [Related]
3. Spectrum of activity of levofloxacin against nontuberculous mycobacteria and its activity against the Mycobacterium avium complex in combination with ethambutol, rifampin, roxithromycin, amikacin, and clofazimine.
Rastogi N; Goh KS; Bryskier A; Devallois A
Antimicrob Agents Chemother; 1996 Nov; 40(11):2483-7. PubMed ID: 8913450
[TBL] [Abstract][Full Text] [Related]
4. Determination of ethambutol MICs for Mycobacterium tuberculosis and Mycobacterium avium isolates by resazurin microtitre assay.
Jadaun GP; Agarwal C; Sharma H; Ahmed Z; Upadhyay P; Faujdar J; Gupta AK; Das R; Gupta P; Chauhan DS; Sharma VD; Katoch VM
J Antimicrob Chemother; 2007 Jul; 60(1):152-5. PubMed ID: 17483147
[TBL] [Abstract][Full Text] [Related]
5. Synergistic effects of antimycobacterial drug combinations on Mycobacterium avium complex determined radiometrically in liquid medium.
Hoffner SE; Svenson SB; Källenius G
Eur J Clin Microbiol; 1987 Oct; 6(5):530-5. PubMed ID: 3436314
[TBL] [Abstract][Full Text] [Related]
6. Susceptibility of mycobacteria to fusidic acid.
Hoffner SE; Olsson-Liljequist B; Rydgård KJ; Svenson SB; Källenius G
Eur J Clin Microbiol Infect Dis; 1990 Apr; 9(4):294-7. PubMed ID: 2112466
[TBL] [Abstract][Full Text] [Related]
7. Susceptibility of multidrug-resistant strains of Mycobacterium tuberculosis to amoxycillin in combination with clavulanic acid and ethambutol.
Abate G; Miörner H
J Antimicrob Chemother; 1998 Dec; 42(6):735-40. PubMed ID: 10052896
[TBL] [Abstract][Full Text] [Related]
8. Rapid phenotypic assay of antimycobacterial susceptibility pattern by direct mycobacteria growth indicator tube and phage amplified biological assay compared to BACTEC 460 TB.
El-Sayed Zaki M; Goda T
Tuberculosis (Edinb); 2007 Mar; 87(2):102-8. PubMed ID: 17035089
[TBL] [Abstract][Full Text] [Related]
9. Combined versus single antituberculosis drugs on the in vitro sensitivity patterns of non-tuberculous mycobacteria.
Banks J; Jenkins PA
Thorax; 1987 Nov; 42(11):838-42. PubMed ID: 3424264
[TBL] [Abstract][Full Text] [Related]
10. In vitro activity of a new isothiazoloquinolone, ACH-702, against Mycobacterium tuberculosis and other mycobacteria.
Molina-Torres CA; Ocampo-Candiani J; Rendón A; Pucci MJ; Vera-Cabrera L
Antimicrob Agents Chemother; 2010 May; 54(5):2188-90. PubMed ID: 20231398
[TBL] [Abstract][Full Text] [Related]
11. In vitro synergistic interactions of oleanolic acid in combination with isoniazid, rifampicin or ethambutol against Mycobacterium tuberculosis.
Ge F; Zeng F; Liu S; Guo N; Ye H; Song Y; Fan J; Wu X; Wang X; Deng X; Jin Q; Yu L
J Med Microbiol; 2010 May; 59(Pt 5):567-572. PubMed ID: 20075118
[TBL] [Abstract][Full Text] [Related]
12. In vitro activity of isoimperatorin, alone and in combination, against Mycobacterium tuberculosis.
Guo N; Wu J; Fan J; Yuan P; Shi Q; Jin K; Cheng W; Zhao X; Zhang Y; Li W; Tang X; Yu L
Lett Appl Microbiol; 2014 Apr; 58(4):344-9. PubMed ID: 24330002
[TBL] [Abstract][Full Text] [Related]
13. Activity of subinhibitory concentrations of dapsone alone and in combination with cell-wall inhibitors against Mycobacterium avium complex organisms.
Rastogi N; Goh KS; Labrousse V
Eur J Clin Microbiol Infect Dis; 1993 Dec; 12(12):954-8. PubMed ID: 8187794
[TBL] [Abstract][Full Text] [Related]
14. In-vitro synergistic activity between ethambutol and fluorinated quinolones against Mycobacterium avium complex.
Hoffner SE; Kratz M; Olsson-Liljequist B; Svenson SB; Källenius G
J Antimicrob Chemother; 1989 Sep; 24(3):317-24. PubMed ID: 2808189
[TBL] [Abstract][Full Text] [Related]
15. Molecular Screening Versus Phenotypic Susceptibility Testing of Multidrug-Resistant Mycobacterium tuberculosis Isolates for Streptomycin and Ethambutol.
Al-Mutairi NM; Ahmad S; Mokaddas E
Microb Drug Resist; 2018 Sep; 24(7):923-931. PubMed ID: 29336677
[TBL] [Abstract][Full Text] [Related]
16. Synergy between Circular Bacteriocin AS-48 and Ethambutol against Mycobacterium tuberculosis.
Aguilar-Pérez C; Gracia B; Rodrigues L; Vitoria A; Cebrián R; Deboosère N; Song OR; Brodin P; Maqueda M; Aínsa JA
Antimicrob Agents Chemother; 2018 Sep; 62(9):. PubMed ID: 29987141
[TBL] [Abstract][Full Text] [Related]
17. Activity of a new class of isonicotinoylhydrazones used alone and in combination with isoniazid, rifampicin, ethambutol, para-aminosalicylic acid and clofazimine against Mycobacterium tuberculosis.
De Logu A; Onnis V; Saddi B; Congiu C; Schivo ML; Cocco MT
J Antimicrob Chemother; 2002 Feb; 49(2):275-82. PubMed ID: 11815568
[TBL] [Abstract][Full Text] [Related]
18. [Distribution and drug resistance of nontuberculous
Zhang J; Su JR; Ding BC; Liu JW; Yi JL; Yang XY; Wang NH; Wang SM
Zhonghua Jie He He Hu Xi Za Zhi; 2017 Mar; 40(3):210-214. PubMed ID: 28297817
[No Abstract] [Full Text] [Related]
19. [Prospects for development of new antituberculous drugs].
Tomioka H
Kekkaku; 2002 Aug; 77(8):573-84. PubMed ID: 12235850
[TBL] [Abstract][Full Text] [Related]
20. Reliability of mycobacteria growth indicator tube for testing susceptibility of Mycobacterium tuberculosis to ethambutol and streptomycin.
Bergmann JS; Woods GL
J Clin Microbiol; 1997 Dec; 35(12):3325-7. PubMed ID: 9399548
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
